The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.

Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.

Market Dynamics

• Growing Prevalence of Chronic Diseases
• Increasing Incidence of Communicable Diseases Due to Needlestick Injuries
• Rise in Demand for Self-Injection Devices

Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016. The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.

Download PDF Brochure@ 

Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Rest of the World (RoW)

North America is expected to dominate the market in 2016, with the U.S. accounting for a major share. However, Europe is expected to grow at the highest CAGR during the forecast period. The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe.

Some key players mentioned in the research report are:

Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

Request for sample pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.

Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.

Market Dynamics

• Growing Prevalence of Chronic Diseases
• Increasing Incidence of Communicable Diseases Due to Needlestick Injuries
• Rise in Demand for Self-Injection Devices

Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016. The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.

Download PDF Brochure@   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861 

Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Rest of the World (RoW)

North America is expected to dominate the market in 2016, with the U.S. accounting for a major share. However, Europe is expected to grow at the highest CAGR during the forecast period. The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe.

Some key players mentioned in the research report are:

Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

Request for sample pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.

Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.

Market Dynamics

• Growing Prevalence of Chronic Diseases
• Increasing Incidence of Communicable Diseases Due to Needlestick Injuries
• Rise in Demand for Self-Injection Devices

Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016. The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Rest of the World (RoW)

North America is expected to dominate the market in 2016, with the U.S. accounting for a major share. However, Europe is expected to grow at the highest CAGR during the forecast period. The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe.

Some key players mentioned in the research report are:

Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

Request for sample pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

The global fuel injection systems market experienced a remarkable growth in the past few years as a result of increasing environmental regulations and concerns relating to carbon emissions. The fuel injection market is anticipated to witness a rapid growth due to consequent requirement for passenger cars, growing population, and better lifestyles. Fuel injections are important constituents in every automotive engine which controls and monitors the quantity of fuel incoming the engine cylinders in accordance with the necessities. The purpose of fuel injection system is to enhance and regulate the air/fuel ratio which comes into the engine of vehicles. The fuel injection system comprises of sensors and electronic components. It should be well regulated to take full advantage of the efficiency and engine power and to diminish consumption of gases.

Get Sample Inquary @ https://bit.ly/3lpOjSO

Gasoline direct injection is an innovative system of injection for gasoline engines and provides enhanced performances and huge reductions in fuel emission and consumption. Fuel injection systems of the cars having gasoline engines are generally secondary and gasoline is being inserted into the inlet port or inlet manifold instead of injecting straight into the combustion chambers. This process helps in ensuring that the fuel is mixed well with the air prior to its entering into the chambers. However, majority of the diesel engines implement the direct injection system. In direct injection, diesel is directly made to enter into the cylinder that is filled with compressed air. Contemporary fuel injection systems along with controlling the movement of fuel, also offer supplementary functions which include pilot, multiple, rate scheduling (shaping) and post injections, which is estimated to contribute fundamentally to the market growth. Several other factors which are expected to be vital for the demand of global fuel injection systems include increased output, reliability and efficiency. The global demand for the market is projected to increase as the fuel injected engines are considerably stress-free to get going, not needing any choke and furthermore saves fuel.

As the diesel fuel injection systems market has witnessed a growth, the market for passenger cars using diesel has also undergone a significant increase worldwide. Adding to it, since the fuel injection systems of 150cc and less has seen huge developments, it has given great opportunities to the two-wheelers for tapping into the market. Furthermore, additional developments in the global fuel injection systems market is expected to drive the demand for the overall market. However, factors including growing difficulties in service and huge costs of maintenance are anticipated to obstruct the global fuel injection systems market growth. Rise in hydrocarbons which are not burnt might also increase the rates of emission. This is expected to hamper the growth of global fuel injection systems market. Furthermore, continuously fluctuating prices of the raw materials is also expected to hamper the growth of Tier I suppliers.

The global fuel injection systems market are used in vehicles such as commercial, buses, two wheelers, passenger and heavy trucks. Passenger car segment witnessed the highest rate of growth due to growing need for personal conveyance and increasing per capita income. On the basis of engine types, the market is segmented into diesel and gasoline, with over all preference given to the gasoline technology as a result of environmental concerns and fuel efficiency. Fuel injection systems market has several technologies such as direct injection of diesel, direct injection of gasoline and port injection. Additionally, on the basis of components, fuel injections systems include pressure regulators, injectors, high pressure pumps and ECU.

To Get Full Report Click Here @ https://bit.ly/3nJDbTZ

The growing passenger cars demand in countries such as Mexico and Canada coupled with greater spending capacity is expected to be responsible for the economic growth of the North American market. Owing to the existence of multinational automotive OEMs in various countries across Europe such as Italy, Spain, Germany and UK have also witnessed increased demand in fuel injection systems market. Countries in Asia Pacific such as India, Australia, Japan and China have also experienced huge improvements in fuel injection systems increasing the demand of the global market. Key industry players in the global fuel injection systems markets have undertaken steps such as mergers & acquisitions to support their market position. Prominent fuel injection systems market players include Delphi Automotive PLC, Continental AG, Denso Corporation, Keihien Corporation, Hitachi Limited, Ucal Fuel Systems Ltd., Magneti Marelli S.p.A., Robert Bosch GmbH and Mikuni Corporation.

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com